Award
NIH Reporter #5R01AI109139-08
Using bile salt metabolism to modulate CDI prophylaxis
Recipient
UNIVERSITY OF NEVADA LAS VEGAS
Award Amount
$725,006.00
Ceiling
$725,006.00
Awarded
August 12, 2026
Identifier
5R01AI109139-08
NIH/NIAID awarded a research project to University of Nevada Las Vegas for $725,006 to develop anti-germinants to prevent Clostridium difficile infection, including synthesis and testing studies.
Description
This is a research project funded by NIH/NIAID focusing on the development of anti-germinants to prevent Clostridium difficile infection (CDI). The project involves synthesis of analogs, efficacy testing, pharmacokinetics, and pharmacodynamics studies. The award amount is approximately $725,006 for the fiscal year 2026. The project is associated with the University of Nevada Las Vegas and is part of the PAR-22-241 funding opportunity.